Increased Activity of ENaC in Proteinuric Kidney Transplant Recipients
Status:
Unknown status
Trial end date:
2020-09-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to determine if amiloride, a diuretic drug, is capable of increasing
renal salt excretion, lowering blood pressure and inhibiting uPA in kidney transplant
recipients with proteinuria compared to normoalbuminuric transplant patients.
Phase:
N/A
Details
Lead Sponsor:
University of Southern Denmark
Collaborators:
Odense University Hospital Region of Southern Denmark